Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.063 | 0.7 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.7 |